GSK

Moderna, Inc., based in Cambridge, MA, is a pioneering biotechnology company focused on developing mRNA medicines to revolutionize the treatment and prevention of diseases. Their innovative approach harnesses the power of Messenger RNA to prompt the immune system to create tools for fighting diseases in a unique and effective way. With a mission to deliver impactful solutions to people worldwide, Moderna's cutting-edge platform enables rapid design, research, and testing of mRNA treatments, allowing for the development of new medicines at an accelerated pace. Committed to accessibility and innovation, Moderna is at the forefront of advancing the field of mRNA medicine to address unmet medical needs and improve global healthcare.Generated from the website

Headquartered in Cambridge, Mass., Biogen Idec specializes in the field of biotechnology. Its core capabilities include drug discovery, research and development. The company s focus is the development of products related to oncology, neurology and immunology. Among the company s products are treatments for B-cell, non-Hodgkin s lymphomas; a treatment for relapsing forms of multiple sclerosis; and a treatment for psoriasis and psoriatic arthritis. In addition, the company has several licensed and dedicated bulk-manufacturing facilities engaged in protein manufacturing. James C. Mullen has been the chief executive officer of Biogen Indec for more than two years. He has been with the drug and biotechnology company for over 17 years. Mullen earned a BS degree from Rensselaer Polytech, and a MBA from Villanova. The company maintains research centers in Cambridge, Mass., and San Diego. Biogen Idec has additional offices in Canada, Australia, Japan and Europe, including international headquarters in Zug, Switzerland. The company currently employs approximately 3,400 people worldwide.

H3 Biomedicine Inc, based in Cambridge, is a dedicated human health care company focused on making strides in Oncology research. Their unwavering commitment is to continue the pursuit of groundbreaking advancements until the global goal of eradicating cancer is achieved. Generated from their website's infomation